e-learning
resources
London 2016
Sunday, 04.09.2016
Lung cancer and immune cells: friends or foes?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment
Joanna Domagała-Kulawik (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Proboszcz, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik
Source:
International Congress 2016 – Lung cancer and immune cells: friends or foes?
Session:
Lung cancer and immune cells: friends or foes?
Session type:
Poster Discussion
Number:
513
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Joanna Domagała-Kulawik (Warsaw, Poland), Iwona Osinska, Anna Stelmaszczyk-Emmel, Malgorzata Proboszcz, Malgorzata Polubiec-Kownacka, Dariusz Dziedzic, Joanna Domagala-Kulawik. Correlation of IL-17A concentration with T regulatory cells in lung cancer microenvironment. Eur Respir J 2016; 48: Suppl. 60, 513
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Definition and history of sarcoidosis
Related content which might interest you:
Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Surface expression of CTLA-4 on CD4/CD25
high
cells in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
A requirement for IKKa in lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Antitumor efficacy of the double suicide genesin lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Surface vs. intracellular CTLA-4 expression in lung cancer
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
CD33
+
CD14
-
CD11b
+
CD66b
+
CD15
+
VEGFR-1
hi
myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Effect of 17-oxo-DHA alone and in combination with gemcitabine on lung cancer cell growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Exploring the volatome of different cancer cell lines
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Comparative analysis of lymphoid subsets in peripheral blood and tumor-infiltrating lymphocytes of lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013
Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Mouse lung adenocarcinoma cell lines reveal Prl2c2 as a novel lung tumor promoter
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept